PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Corporation

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PROCEPT BioRobotics (PRCT) and Achieve Life Scienc...

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Achieve Life Sciences (ACHV)

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is facing a federal securities lawsuit alleging that investors were misled about handpiece sales, pr...

PROCEPT BioRobotics Lawsuit Alleges Investors Were Misled Before PRCT Stock Drops

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Stevanato Group (STVN), Ultragenyx Pharmaceutical ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Stevanato Group (STVN), Ultragenyx Pharmaceutical (RARE) and PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics received a Hold rating and price target from William Blair analyst Brandon Vazquez today. Vazquez covers the Healthcare sector,...

William Blair downgrades PROCEPT BioRobotics (PRCT) to a Hold

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is facing a federal securities lawsuit alleging that the company overstated demand for its single-us...

PROCEPT BioRobotics Lawsuit Puts PRCT Investor Losses in Focus After Alleged Handpiece Demand Disclosures 

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCE...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$21.51	+5.39%	596.93K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRCT	$21.51	+5.4%	596.93K
3
4
5
6

PRCT

PRCT

Get PROCEPT BioRobotics Corporation Data in Excel

Get PROCEPT BioRobotics Corporation Data in Excel